Verrica Pharmaceuticals Inc. (VRCA)

NASDAQ: VRCA · Real-Time Price · USD

6.05

+0.54 (9.80%)

At close: Feb 18, 2026, 4:00 PM EST

6.07

+0.02 (0.33%)

After-hours: Feb 18, 2026, 4:04 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Novel Topical Solution of Cantharidin	5.12M
Novel Topical Solution of Cantharidin Growth	-43.27%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States	5.12M
United States Growth	-43.27%